Home » Topics » Disease categories and therapies » Ocular

Ocular
RSS

New therapeutic option for glaucoma reported in recent Organon patent

April 16, 2008

Lpath submits IND application to FDA for iSONEP in age-related macular degeneration

April 16, 2008

Jerini and PR collaborate on sustained-release formulations of ophthalmic drugs

April 16, 2008

Potentia completes round of financing to advance POT-4 clinical program in AMD

April 14, 2008

Cationorm launched in France for dry eye symptoms

April 11, 2008

Visual stability seen with pegaptanib maintenance therapy in neovascular AMD

April 9, 2008

Ranibizumab under study in patients with pigment epithelial detachments

April 9, 2008

Reduced retinal thickness seen with VEGF Trap-Eye in neovascular AMD

April 9, 2008

Recent data on bevacizumab in ocular disorders presented

April 9, 2008

Novel antiglaucoma agents disclosed in recent Allergan patent

April 8, 2008

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 7, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...
Bio Korea 2026: US policy risks shift to execution framework
BioWorld
Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...
Regulatory actions for May 5, 2026
BioWorld
Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Adma, Applied...